Insufficient scRNA-seq data for expression of MPL at single-cell level.
Insufficient scRNA-seq data for expression of MPL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 94% | 13.14 | 230 / 245 | 64% | 0.96 | 322 / 502 |
ovary | 97% | 31.36 | 175 / 180 | 50% | 0.92 | 216 / 430 |
thymus | 98% | 20.90 | 643 / 653 | 47% | 0.74 | 283 / 605 |
esophagus | 92% | 13.93 | 1328 / 1445 | 36% | 0.85 | 66 / 183 |
brain | 89% | 15.77 | 2350 / 2642 | 35% | 0.65 | 244 / 705 |
kidney | 83% | 9.46 | 74 / 89 | 40% | 0.64 | 356 / 901 |
lung | 97% | 36.99 | 563 / 578 | 20% | 0.31 | 232 / 1155 |
breast | 98% | 20.79 | 450 / 459 | 19% | 0.29 | 207 / 1118 |
uterus | 98% | 18.84 | 167 / 170 | 14% | 0.23 | 62 / 459 |
intestine | 92% | 12.08 | 891 / 966 | 13% | 0.19 | 69 / 527 |
pancreas | 84% | 8.67 | 276 / 328 | 21% | 0.42 | 37 / 178 |
stomach | 82% | 8.67 | 296 / 359 | 20% | 0.34 | 58 / 286 |
adipose | 95% | 20.37 | 1146 / 1204 | 0% | 0 | 0 / 0 |
spleen | 94% | 14.29 | 227 / 241 | 0% | 0 | 0 / 0 |
bladder | 86% | 14.76 | 18 / 21 | 8% | 0.12 | 41 / 504 |
blood vessel | 93% | 14.07 | 1248 / 1335 | 0% | 0 | 0 / 0 |
heart | 92% | 14.72 | 790 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 79% | 7.60 | 205 / 258 | 6% | 0.08 | 13 / 230 |
skin | 68% | 8.39 | 1227 / 1809 | 3% | 0.06 | 16 / 472 |
peripheral blood | 69% | 10.44 | 639 / 929 | 0% | 0 | 0 / 0 |
muscle | 62% | 5.00 | 499 / 803 | 0% | 0 | 0 / 0 |
liver | 35% | 2.20 | 78 / 226 | 8% | 0.13 | 34 / 406 |
eye | 0% | 0 | 0 / 0 | 5% | 0.06 | 4 / 80 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.06 | 2 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001780 | Biological process | neutrophil homeostasis |
GO_0038163 | Biological process | thrombopoietin-mediated signaling pathway |
GO_0050671 | Biological process | positive regulation of lymphocyte proliferation |
GO_0016064 | Biological process | immunoglobulin mediated immune response |
GO_1905221 | Biological process | positive regulation of platelet formation |
GO_1990959 | Biological process | eosinophil homeostasis |
GO_0035702 | Biological process | monocyte homeostasis |
GO_1990960 | Biological process | basophil homeostasis |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0009986 | Cellular component | cell surface |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0031965 | Cellular component | nuclear membrane |
GO_0043025 | Cellular component | neuronal cell body |
GO_0038164 | Molecular function | thrombopoietin receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | MPL |
Protein name | Thrombopoietin receptor variant MPL proto-oncogene, thrombopoietin receptor Thrombopoietin receptor (TPO-R) (Myeloproliferative leukemia protein) (Proto-oncogene c-Mpl) (CD antigen CD110) MPL Myeloproliferative leukemia protein |
Synonyms | TPOR |
Description | FUNCTION: Receptor for thrombopoietin that acts as a primary regulator of megakaryopoiesis and platelet production. May represent a regulatory molecule specific for TPO-R-dependent immune responses. . |
Accessions | Q5JUY5 P40238 A0A142IKC6 A0A142IKC3 W8QGV4 A0A2H4PKE3 A0A2R8YE13 ENST00000413998.7 ENST00000372470.9 [P40238-1] ENST00000643351.1 |